Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Yu, Y"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 458
Tytuł:
LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusion.
Autorzy:
Mori S; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan.
Izumi H; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan.
Araki M; Graduate School of Medicine, Kyoto University, Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
Liu J; Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, 277-8577, Japan.
Tanaka Y; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan.
Kagawa Y; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan.
Sagae Y; Graduate School of Medicine, Kyoto University, Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
Ma B; RIKEN Center for Computational Science, Kobe, Hyogo, 650-0047, Japan.
Isaka Y; RIKEN Center for Computational Science, Kobe, Hyogo, 650-0047, Japan.
Sasakura Y; RIKEN Center for Computational Science, Kobe, Hyogo, 650-0047, Japan.
Kumagai S; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, 277-8577, Japan.
Sakae Y; Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, 277-8577, Japan.
Tanaka K; Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, 277-8577, Japan.
Shibata Y; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan.
Udagawa H; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan.
Matsumoto S; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan.
Yoh K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan.
Okuno Y; Graduate School of Medicine, Kyoto University, Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan.
Kobayashi SS; Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, 277-8577, Japan. .; Department of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, 277-8561, Japan. .; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2024 Apr 04; Vol. 7 (1), pp. 412. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Aminopyridines*
Lactams*
Pyrazoles*
Humans ; Anaplastic Lymphoma Kinase/genetics ; Anaplastic Lymphoma Kinase/therapeutic use ; Drug Resistance, Neoplasm/genetics ; Lactams, Macrocyclic/pharmacology ; Lactams, Macrocyclic/therapeutic use ; Mutation ; Cytoskeletal Proteins/genetics ; Receptor Protein-Tyrosine Kinases/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer.
Autorzy:
Luo WC; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Mei SQ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Huang ZJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Chen ZH; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Zhang YC; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Yang MY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; School of Medicine, South China University of Technology, Guangzhou, China.
Liu JQ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Xu JY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Yang XR; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; School of Medicine, South China University of Technology, Guangzhou, China.
Zhong RW; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; School of Medicine, South China University of Technology, Guangzhou, China.
Tang LB; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; School of Medicine, South China University of Technology, Guangzhou, China.
Yin LX; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Deng Y; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Peng YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; School of Medicine, South China University of Technology, Guangzhou, China.
Lu C; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Chen BL; Xiamen Treatgut Biotechnology Co., Ltd, Xiamen, China.
Ke DX; Xiamen Treatgut Medical Laboratory Co., Ltd, Xiamen, China.
Tu HY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Yang JJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Xu CR; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Apr 02; Vol. 22 (1), pp. 326. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/therapy
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/therapy
Lung Neoplasms*/drug therapy
Gastrointestinal Microbiome*
Humans ; Immunotherapy ; ErbB Receptors/genetics ; Anti-Bacterial Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma.
Autorzy:
Zhang Y; Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650302, Yunnan, China.
Jia Q; Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650302, Yunnan, China.
Li F; Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650302, Yunnan, China.
Luo X; Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650302, Yunnan, China.
Wang Z; Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650302, Yunnan, China.
Wang X; Department of Pathology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Wang Y; Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650302, Yunnan, China.
Zhang Y; Wenshan People's Hospital, Yunnan, Yunnan Province, China.
Li M; Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650302, Yunnan, China.
Bian L; Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650302, Yunnan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 30; Vol. 14 (1), pp. 7543. Date of Electronic Publication: 2024 Mar 30.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/genetics
Adenine/*analogs & derivatives
Humans ; Prognosis ; Nomograms
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves.
Autorzy:
Dou X; School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China.
Lu J; School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China.
Yu Y; School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China.
Yi Y; School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China.
Zhou L; School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2024 Mar 21; Vol. 2024, pp. 4782618. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnosis
Male ; Humans ; Female ; Biomarkers, Tumor ; ROC Curve ; Carcinoembryonic Antigen ; Retrospective Studies ; Early Detection of Cancer ; Antigens, Neoplasm ; Keratin-19
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Longitudinal circulating tumour DNA dynamics predict failure patterns and efficacy of consolidation immunotherapy after chemoradiotherapy in locally advanced non-small-cell lung cancer.
Autorzy:
Wang Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhang T; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yang Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang J; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li C; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xu X; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wu Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jiang Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Duan J; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang L; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
Bi N; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2024 Mar; Vol. 14 (3), pp. e1619.
Typ publikacji:
Letter
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/therapy
Circulating Tumor DNA*/genetics
Lung Neoplasms*/therapy
Humans ; Chemoradiotherapy ; Immunotherapy
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
5-Methoxytryptophan enhances the sensitivity of sorafenib on the inhibition of proliferation and metastasis for lung cancer cells.
Autorzy:
Chen HC; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Kuo CY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chang Y; Department of Obstetrics and Gynecology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.; School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
Tsai DL; Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Division of Chest Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lee MH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lee JY; Division of Chest Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lee HM; Division of General Surgery, Department of Surgery, E-Da Cancer Hospital, Kaohsiung, Taiwan.; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
Su YC; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan. .; Division of Hematology-Oncology, Department of Internal Medicine, E-Da Hospital, Kaohsiung, Taiwan. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 22; Vol. 24 (1), pp. 248. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Tryptophan/*analogs & derivatives
Humans ; Sorafenib/pharmacology ; Sorafenib/therapeutic use ; Cell Line, Tumor ; Cell Proliferation ; Xenograft Model Antitumor Assays ; Phenylurea Compounds/pharmacology ; Phenylurea Compounds/therapeutic use ; Apoptosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PDGFBB facilitates tumorigenesis and malignancy of lung adenocarcinoma associated with PI3K-AKT/MAPK signaling.
Autorzy:
Xiu-Ying H; Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.; Institute of Neurological Disease, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Yue-Xiang Z; School of Integrated Traditional Chinese and Western Medicine, Southwest Medical University, Luzhou, China.
Hui-Si Y; School of Integrated Traditional Chinese and Western Medicine, Southwest Medical University, Luzhou, China.
Hong-Zhou Y; Institute of Neurological Disease, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Qing-Jie X; Institute of Neurological Disease, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. .
Ting-Hua W; Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China. wangth_.; Institute of Neurological Disease, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. wangth_.; Laboratory Zoology Department, Institute of Neuroscience, Kunming Medical University, Kunming, China. wangth_.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 20; Vol. 14 (1), pp. 4191. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/pathology
Humans ; Becaplermin/metabolism ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Cell Transformation, Neoplastic/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Cell Movement/genetics ; Cell Line, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Discovery of lung adenocarcinoma tumor antigens and ferroptosis subtypes for developing mRNA vaccines.
Autorzy:
Chen Y; Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangxi Medical University, Daxue East Road No.166, Nanning, 530007, Guangxi, China.
Zhang C; Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangxi Medical University, Daxue East Road No.166, Nanning, 530007, Guangxi, China.
Li Y; Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangxi Medical University, Daxue East Road No.166, Nanning, 530007, Guangxi, China.
Tan X; Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangxi Medical University, Daxue East Road No.166, Nanning, 530007, Guangxi, China.
Li W; Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangxi Medical University, Daxue East Road No.166, Nanning, 530007, Guangxi, China.
Tan S; Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangxi Medical University, Daxue East Road No.166, Nanning, 530007, Guangxi, China.
Liu G; Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangxi Medical University, Daxue East Road No.166, Nanning, 530007, Guangxi, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 08; Vol. 14 (1), pp. 3219. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Ferroptosis*/genetics
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/genetics
Humans ; Antigens, Neoplasm/genetics ; mRNA Vaccines ; RNA, Messenger/genetics ; Membrane Proteins/genetics ; RNA-Binding Proteins ; Nerve Tissue Proteins ; Connexins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The inhibitory effect of apatinib on different small cell lung cancer cells and in lung cancer-bearing mice and patients.
Autorzy:
Liu M; Department of Pulmonary Medicine, Binzhou People's Hospital, Binzhou, Shandong, China.
Li H; Department of Pulmonary Medicine, Binzhou People's Hospital, Binzhou, Shandong, China.
Guo R; Department of Pulmonary Medicine, Binzhou People's Hospital, Binzhou, Shandong, China.
Yu X; Department of Pulmonary Medicine, Penglai Traditional Chinese Medicine Hospital, Yantai, Shandong, China.
Li Y; Department of Pulmonary Medicine, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2024 Feb; Vol. 18 (2), pp. e13738.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Small Cell Lung Carcinoma*/drug therapy
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Pyridines*
Humans ; Animals ; Mice ; Cell Line, Tumor ; Signal Transduction ; Cell Proliferation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of blood cell-based inflammatory markers with gut microbiota and cancer incidence in the Rotterdam study.
Autorzy:
Najjary S; Department of Pathology and Clinical Bioinformatics, The Tumor Immuno-Pathology Laboratory, Erasmus University Medical Center, Rotterdam, the Netherlands.
Kros JM; Department of Pathology and Clinical Bioinformatics, The Tumor Immuno-Pathology Laboratory, Erasmus University Medical Center, Rotterdam, the Netherlands.
Stricker BH; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Ruiter R; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Shuai Y; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Kraaij R; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Van Steen K; Department of Human Genetics, Laboratory for Systems Medicine, Center for Human Genetics, KU Leuven, Leuven, Belgium.
van der Spek P; Department of Pathology and Clinical Bioinformatics, The Tumor Immuno-Pathology Laboratory, Erasmus University Medical Center, Rotterdam, the Netherlands.
Van Eijck CHJ; Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.
Ikram MA; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Ahmad S; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6860. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
Gastrointestinal Microbiome*
Lung Neoplasms*
Humans ; Incidence ; Body Mass Index ; Inflammation/epidemiology ; Blood Cells
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Autorzy:
Lin G; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wang Z; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hu Y; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, China.
Huang D; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Wang J; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji'nan, China.
Yang F; Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.
Zhong W; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Zhou C; Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zhu B; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China.
Ai X; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cao B; Department of Medical Oncology and Radiation Sickness, Cancer Center, Peking University Third Hospital, Beijing, China.
Cao Y; Department of oncology, Kiang Wu Hospital, Macau, China.
Chen M; Department of Thoracic Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Chen X; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Chu T; Respiratory Department, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Duan J; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Fan Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhenjiang University School of Medicine, Hangzhou, China.
Feng S; Department of Medical Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen, China.
Feng W; Department of Pulmonary Oncology, The First People's Hospital of Foshan, Foshan, China.
Guo H; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Han C; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
He Y; Department of Respiratory Medicine, Xinqiao Hospital, Army Medical University, Chongqing, China.
Hong S; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Hu J; Shanghai Geriatric Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Huang M; Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Huang Y; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Jiang D; Department of Oncology, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.
Jiang K; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Jiang R; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Jin B; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, China.
Jin S; National Cancer Center/National Clinical Research Cencer for Cancer/Cancer Hospital &Shenzhen Hospital, Chinese Academy of Medical Sciences and Perking Union Medical College, Shenzhen, China.
Li J; Department of Medical Oncology, Qilu Hospital of Shandong University, Ji'nan, China.
Li M; Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China.
Li Z; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Li C; Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Lin J; Department of Medical Oncology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Liu A; Department of Medical Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Liu SM; Department of Hematology, First Affiliated Hospital, Ji'nan University, Guangzhou, China.
Yutao L; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu Z; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, China.
Liu Z; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Liu Z; Department of Oncology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China.
Liu Z; Department of Thoracic Oncology, Jiangxi Cancer Hospital, Nanchang, China.
Liu Z; Cancer Center, The 10th Affiliated Hospital of Southern Medical University, Dongguan, China.
Lu Y; Department of Abdominal Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Lv T; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Ma Z; Department of Respiratory Medicine, Henan cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Miao Q; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Peng M; Cancer cenrter, Renmin Hospital of Wuhan University, Wuhan, China.
Pu X; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Ren XB; Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Shan J; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University, Zhejiang, China.
Shan J; Department of Medical Oncology, Daping Hospital, Army Medical University, Chongqing, China.
Shen P; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Shen B; Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Shi M; Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Song Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Song Z; Department of Clinical Trial, Zhejiang Cancer Hospital, Hangzhou, China.
Su C; Department of Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Sun J; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China.
Tian P; Precision Medicine Key Laboratory of Sichuan Province, Department of Pulmonary and Critical Care Medicine, Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Wang J; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, China.
Wang F; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wang H; Department of Respiratory Medicine, Henan cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Wang J; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Wang W; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Wang Y; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China.
Xia Y; Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Xie C; Department of Radiation and Medical Oncology, Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xie C; Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xin T; Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiong J; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Xu H; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Xu S; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Xu Y; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Xu B; Cancer cenrter, Renmin Hospital of Wuhan University, Wuhan, China.
Xu C; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Yan X; Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, China.
Yang Z; Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yao W; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Yu Y; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Feng Y; Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Yu Z; Department of Respiratory Medicine, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army of China, Fuzhou, China.
Yu Y; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yue D; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zhang H; Department of Oncology, Guangdong Provicial Hospital of Chinese Medicine, Guangzhou, China.
Zhang H; Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Zhang L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang L; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhang Q; Institute of Immunotherapy, Fujian Medical University, Fuzhou, China.
Zhang T; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Zhang B; Cancer cenrter, Renmin Hospital of Wuhan University, Wuhan, China.
Zhao J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department I of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Zhao M; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, China.
Zheng X; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhong Q; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhou J; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Zhou P; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zou J; Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zou Z; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (5), pp. 419-426. Date of Electronic Publication: 2024 Jan 14.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Consensus ; Immunotherapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
TPI1 promotes MAPK/ERK-induced EMT, cell migration and invasion in lung adenocarcinoma.
Autorzy:
Li Y; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Pan B; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Department of Cardiothoracic Surgery, People's Hospital Affiliated to Jiangsu University, Zhenjiang, China.
Zhang F; Soochow University Medical College, Suzhou, China.
Jia X; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhu X; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Tong X; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhao J; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Li C; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (4), pp. 327-338. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Humans ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Epithelial-Mesenchymal Transition ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High efficacy of brigatinib for brain metastases in ALK fusion gene-positive non-small cell lung cancer: A case series.
Autorzy:
Morikawa K; Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Numata Y; Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Shinozaki Y; Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Kaneko S; Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Matsushima A; Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Nishida M; Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Kida H; Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Handa H; Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Nishine H; Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Mineshita M; Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (6), pp. 496-499. Date of Electronic Publication: 2023 Dec 30.
Typ publikacji:
Case Reports
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/secondary
Organophosphorus Compounds*
Pyrimidines*
Female ; Humans ; Anaplastic Lymphoma Kinase ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma.
Autorzy:
Huang G; Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.
Zhang X; Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.
Xu Y; Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.
Chen S; Department of Orthopedics, Jishuitan Hospital of Beijing, Beijing, China.
Cao Q; Department of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Liu W; Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.
Fu Y; Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.
Jia Q; Guangzhou City Polytechnic, Guangzhou, China.
Shen J; Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Yin J; Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China. .; Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. .
Zhang J; Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Jan 22; Vol. 22 (1), pp. 88. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Osteosarcoma*/genetics
Lung Neoplasms*/genetics
Bone Neoplasms*/genetics
Humans ; Prognosis ; Retrospective Studies ; Biomarkers ; beta-Lactamases ; Membrane Proteins ; Mitochondrial Proteins ; Repressor Proteins ; Forkhead Transcription Factors ; Serine-Arginine Splicing Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Circular RNA hsa_circ_0050386 suppresses non-small cell lung cancer progression via regulating the SRSF3/FN1 axis.
Autorzy:
Chen J; The State Key Lab of Respiratory Disease, The School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.; Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, 510180, China.
Rao B; The State Key Lab of Respiratory Disease, The School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Huang Z; The State Key Lab of Respiratory Disease, The School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Xie C; The State Key Lab of Respiratory Disease, The School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Yu Y; The State Key Lab of Respiratory Disease, The School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Yang B; Department of Central Laboratory, The 5th Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510700, China.
Wu D; Guangzhou Center for Disease Control and Prevention, Guangzhou, 510440, China.
Wang D; Guangzhou Center for Disease Control and Prevention, Guangzhou, 510440, China.
Qiu F; The State Key Lab of Respiratory Disease, The School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Zhou Y; Department of Genetics, Medical College of Soochow University, Suzhou, 215123, China.
Deng Y; Centre for Medical Laboratory Science, the Affiliated Hospital of Youjiang Medical University for Nationalities, No. 18 Zhongshaner Rd., Youjiang District, Baise, 533000, China. .
Lu J; The State Key Lab of Respiratory Disease, The First Affiliated Hospital, The School of Public Health, Guangzhou Medical University, Xinzao Town, Panyu District, Guangzhou, 511436, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Jan 12; Vol. 22 (1), pp. 47. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/genetics
MicroRNAs*
Humans ; Cell Line, Tumor ; Cell Proliferation/genetics ; Fibronectins ; Gene Expression Regulation, Neoplastic ; RNA/genetics ; RNA, Circular/genetics ; Serine-Arginine Splicing Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Synergistic cerium oxide nanozymes: targeting DNA damage and alleviating tumor hypoxia for improved NSCLC radiotherapy efficiency.
Autorzy:
Liu J; Department of Cardiothoracic Surgery, Southwest Hospital, Army Medical University, 30 Gaotanyan Main St, Chongqing, 400038, China.
Liu C; Department of Oncology, Southwest Hospital, Army Medical University, 30 Gaotanyan Main St, Chongqing, 400038, China.
Tang J; Department of Cardiothoracic Surgery, Southwest Hospital, Army Medical University, 30 Gaotanyan Main St, Chongqing, 400038, China.
Chen Q; Department of Cardiothoracic Surgery, Southwest Hospital, Army Medical University, 30 Gaotanyan Main St, Chongqing, 400038, China.
Yu Y; Department of Cardiothoracic Surgery, Southwest Hospital, Army Medical University, 30 Gaotanyan Main St, Chongqing, 400038, China.
Dong Y; Department of Oncology, Southwest Hospital, Army Medical University, 30 Gaotanyan Main St, Chongqing, 400038, China. .
Hao J; Department of Oncology, Southwest Hospital, Army Medical University, 30 Gaotanyan Main St, Chongqing, 400038, China. .
Wu W; Department of Cardiothoracic Surgery, Southwest Hospital, Army Medical University, 30 Gaotanyan Main St, Chongqing, 400038, China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2024 Jan 10; Vol. 22 (1), pp. 25. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Lung Neoplasms*/drug therapy
Lung Neoplasms*/radiotherapy
Humans ; Hydrogen Peroxide ; Tumor Hypoxia ; DNA Damage ; Hypoxia/drug therapy ; Quercetin ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combining TIGIT blockade with IL-15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma.
Autorzy:
Luo B; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Sun Y; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Zhan Q; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Luo Y; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Chen Y; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Fu T; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Yang T; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Ren L; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Xie Z; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Situ X; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Liu B; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Tang K; Division of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Ke Z; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2024 Jan; Vol. 14 (1), pp. e1553.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/therapy
Adenocarcinoma of Lung*/metabolism
Lung Neoplasms*/therapy
Lung Neoplasms*/metabolism
Animals ; Humans ; Mice ; CD8-Positive T-Lymphocytes ; Disease Models, Animal ; Immunotherapy ; Interleukin-15/pharmacology ; Receptors, Immunologic/genetics ; Receptors, Immunologic/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The D ~ Sense ex-vivo viability assay application in a patient with stage IV lung adenocarcinoma: a case report.
Autorzy:
Zhang Y; Nanjing Chest Hospital, Nanjing, 210029, China.
Wu X; Nanjing Chest Hospital, Nanjing, 210029, China.
He P; Department of Pathology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, China.
Wu J; Department of Pathology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, China.; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17165, Stockholm, Sweden.
Gu X; Department of Pathology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, China.
Bendek M; Department of Pathology/Cytology, Karolinska University Laboratory, Karolinska University Hospital Huddinge, Huddinge, 14186, Stockholm, Sweden.
Ötvös R; Department of Pathology/Cytology, Karolinska University Laboratory, Karolinska University Hospital Huddinge, Huddinge, 14186, Stockholm, Sweden.
Szekely L; Department of Pathology/Cytology, Karolinska University Laboratory, Karolinska University Hospital Huddinge, Huddinge, 14186, Stockholm, Sweden. .
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Dec 24; Vol. 17 (1), pp. 529. Date of Electronic Publication: 2023 Dec 24.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Carcinoma, Non-Small-Cell Lung*/pathology
Adenocarcinoma of Lung*/drug therapy
Male ; Humans ; Adult ; ErbB Receptors/genetics ; Protein Kinase Inhibitors/therapeutic use ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Discovery of novel 2-aminopyridine derivatives as ROS1 and ALK dual inhibitors to combat drug-resistant mutants including ROS1 .
Autorzy:
Liu S; Affiliated Foshan Maternity & Child Healthcare Hospital, Southern Medicinal University (Foshan Maternity & Child Healthcare Hospital), Foshan, China.; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Huang C; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Huang C; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Huang Y; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Yu Y; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Wu G; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Guo F; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Jiang Y; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Wan S; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Zhu Z; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Tian Y; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Zhu J; Affiliated Foshan Maternity & Child Healthcare Hospital, Southern Medicinal University (Foshan Maternity & Child Healthcare Hospital), Foshan, China.
Zhang J; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Pokaż więcej
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2023 Dec; Vol. 38 (1), pp. 2227779.
Typ publikacji:
Journal Article
MeSH Terms:
Protein-Tyrosine Kinases*
Lung Neoplasms*
Humans ; Anaplastic Lymphoma Kinase ; Drug Resistance, Neoplasm ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/chemistry ; Crizotinib/pharmacology ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/chemistry ; Mutation ; Cell Line, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.
Autorzy:
Huang D; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Lin G; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Hu Y; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Wang J; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji'nan, People's Republic of China.
Wang Z; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Yang F; Department of Thoracic Surgery, Peking University People Hospital, Beijing, People's Republic of China.
Zhong W; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
Zhou C; Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Zhu B; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, People's Republic of China.
Ai X; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Cao B; Cancer center, Peking University Third Hospital/ Department of medical oncology and radiation sickness, Peking University Third Hospital, Beijing, People's Republic of China.
Cao Y; Department of oncology, Kiang Wu Hospital, Macau, People's Republic of China.
Chen M; Department of Thoracic Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Chen X; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Chu T; Respiratory Department, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Duan J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Fan Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhenjiang University School of Medicine, Hangzhou, People's Republic of China.
Feng S; Department of Medical Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen, People's Republic of China.
Feng W; Department of Pulmonary Oncology, The First People's Hospital of Foshan, Foshan, People's Republic of China.
Guo H; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Han C; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China.
He Y; Department of Respiratory Medicine, Xinqiao Hospital, Army Medical University, Chongqing, People's Republic of China.
Hong S; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Hu J; Zhongshan Hospital, Fudan University, Shanghai Geriatric Center, Shanghai, People's Republic of China.
Huang M; Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Huang Y; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Jiang D; Department of Oncology, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Jiang K; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Jiang R; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Jin B; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, People's Republic of China.
Jin S; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital &Shenzhen Hospital, Chinese Academy of Medical Sciences and Perking Union Medical College, Shenzhen, People's Republic of China.
Li J; Department of Medical Oncology, Qilu Hospital of Shandong University, Ji'nan, People's Republic of China.
Li M; Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Li Z; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Li C; Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Lin J; Department of Medical Oncology, The Second Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China.
Liu A; Department of Medical Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Liu SM; Department of Hematology, First Affiliated Hospital, Ji'nan University, Guangzhou, People's Republic of China.
Liu Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Liu Z; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Liu Z; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
Liu Z; Department of Oncology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, People's Republic of China.
Liu Z; Department of Thoracic Oncology，Jiangxi Cancer Hospital, Nanchang, People's Republic of China.
Liu Z; Cancer Center, The 10th Affiliated Hospital of Southern Medical University, Dongguan, People's Republic of China.
Lu Y; Department of Abdominal Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Lv T; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Ma Z; Department of Respiratory Medicine, Henan Cancer Hospital /Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Miao Q; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Peng M; Cancer center, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Pu X; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Ren XB; Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Shan J; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University, Zhejiang, People's Republic of China.
Shan J; Department of Medical Oncology, Daping Hospital, Army Medical University, Chongqing, People's Republic of China.
Shen P; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Shen B; Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Shi M; Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Song Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Song Z; Department of Clinical Trial, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
Su C; Department of Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, People's Republic of China.
Sun J; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, People's Republic of China.
Tian P; Department of Pulmonary and Critical Care Medicine, Lung Cancer Center, West China Hospital, Sichuan University, Precision Medicine Key Laboratory of Sichuan Province, Chengdu, People's Republic of China.
Wang J; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Wang F; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Wang H; Department of Respiratory Medicine, Henan Cancer Hospital /Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Wang J; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, People's Republic of China.
Wang W; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
Wang Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Xia Y; Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Xie C; Department of Radiation and Medical Oncology, Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.
Xie C; Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Xin T; Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Xiong J; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Xu H; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Xu S; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Xu Y; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Xu B; Cancer center, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Xu C; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Yan X; Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, People's Republic of China.
Yang Z; Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Yao W; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
Yu Y; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Feng Y; Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
Yu Z; Department of Respiratory Medicine, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army of China, Fuzhou, People's Republic of China.
Yu Y; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Yue D; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Zhang H; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, People's Republic of China.
Zhang H; Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi'an, People's Republic of China.
Zhang L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Zhang L; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Zhang Q; Institute of Immunotherapy, Fujian Medical University, Fuzhou, People's Republic of China.
Zhang T; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
Zhang B; Cancer center, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Zhao J; Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department I of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, People's Republic of China.
Zhao M; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, People's Republic of China.
Zheng X; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Zhong F; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Zhou J; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
Zhou P; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Zou J; Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Zou Z; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Dec; Vol. 14 (34), pp. 3421-3429. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/pathology
Humans ; Immunotherapy/methods ; Neoadjuvant Therapy ; B7-H1 Antigen
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 458

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies